Article
Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I.
International journal of antimicrobial agents - 1 May 2014
Huang Yanqin, Xu Yunhua, Liu Shicong, Wang Hailin, Xu Xiaogang, Guo Qinglan, Wu Baixue, Gordeev Mikhail F, Wang Wen, Yuan Zhengyu, Wang Minggui
Abstract excerpt
MRX-I is a new oxazolidinone antimicrobial under development. In this study, the potential for development of resistance to MRX-I in Staphylococcus aureus was investigated and key mutations were characterised. Determination of spontaneous resistance frequency and the mutant selection window (MSW) were performed with meticillin-susceptible S. aureus (MSSA) ATCC 29213, meticillin-resistant S. aureus (MRSA) ATCC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
